BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Miraca Holdings Incorporated
sales of 204.67 billion Japanese Yen [US$1.71 billion]
of which 65%
was Clinical Examination),
Falco Holdings Co Ltd
(46.59 billion Japanese Yen [US$388.59 million]
Medical & Biological Laboratories Company Limited
(7.61 billion Japanese Yen [US$63.47 million]
BML Inc reported sales of ¥104.40 billion (US$870.73 million)
March of 2015.
increase of 5.4%
versus 2014, when the company's sales were ¥99.05 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2010, sales have increased a total of 32%).